Medical consensus shifts on daily aspirin for primary cardiovascular prevention

Clinical guidelines are increasingly advising against routine daily aspirin for primary prevention of heart attacks in healthy adults due to bleeding risks. The shift reflects updated risk-benefit analyses, though aspirin remains standard for secondary prevention in patients with established cardiovascular disease.